Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.

@article{Glue2017KetaminesDE,
  title={Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.},
  author={Paul W Glue and Natalie J. Medlicott and Sarah Harland and Shona M Neehoff and Bridie Anderson-Fahey and Martin Le Nedelec and Andrew R. Gray and N McNaughton},
  journal={Journal of psychopharmacology},
  year={2017},
  volume={31 10},
  pages={
          1302-1305
        }
}
The N-methyl-D-aspartate receptor antagonist ketamine has rapid onset activity in treatment-resistant depression, post-traumatic stress disorder and obsessive compulsive disorder. Due to similarities in brain network activity in depression and anxiety disorders, we hypothesized that ketamine might also be active in other refractory anxiety disorders. We evaluated the efficacy and safety of ketamine in 12 patients with refractory generalized anxiety disorder and/or social anxiety disorder who… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

The assessment of anxiety states by rating

  • M Hamilton
  • Br J Med Psychol
  • 1959
Highly Influential
6 Excerpts

Similar Papers

Loading similar papers…